Dimensional Fund Advisors’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.3M Buy
325,440
+114,767
+54% +$6.65M 0.01% 1824
2025
Q4
$8.68M Buy
210,673
+201,984
+2,325% +$7.83M ﹤0.01% 2331
2025
Q3
$342K Buy
+8,689
New +$222K ﹤0.01% 3051
2024
Q3
Sell
-19,726
Closed -$510K 3362
2024
Q2
$510K Sell
19,726
-2,002
-9% -$48.1K ﹤0.01% 3023
2024
Q1
$652K Buy
21,728
+6,992
+47% +$152K ﹤0.01% 2998
2023
Q4
$153K Buy
+14,736
New +$163K ﹤0.01% 3231
2023
Q1
Sell
-9,562
Closed -$60 3477
2022
Q4
$60 Hold
9,562
﹤0.01% 3379
2022
Q3
$216K Sell
9,562
-318
-3% -$8.71K ﹤0.01% 3220
2022
Q2
$189K Sell
9,880
-878
-8% -$21.7K ﹤0.01% 3254
2022
Q1
$500K Sell
10,758
-480
-4% -$26.2K ﹤0.01% 3153
2021
Q4
$797K Sell
11,238
-740
-6% -$74.4K ﹤0.01% 3076
2021
Q3
$1.4M Sell
11,978
-7,204
-38% -$839K ﹤0.01% 2954
2021
Q2
$3M Buy
19,182
+7,317
+62% +$1.34M ﹤0.01% 2757
2021
Q1
$2.25M Buy
11,865
+5,943
+100% +$1M ﹤0.01% 2824
2020
Q4
$743K Buy
5,922
+1,181
+25% +$134K ﹤0.01% 3035
2020
Q3
$516K Buy
4,741
+121
+3% +$14.3K ﹤0.01% 3056
2020
Q2
$555K Buy
4,620
+2,609
+130% +$368K ﹤0.01% 3058
2020
Q1
$202K Buy
+2,011
New +$373K ﹤0.01% 3208

Other funds holding DNTH

Dimensional Fund Advisors's DNTH Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Dianthus Therapeutics (DNTH) stake by 54% in Q1 2026, buying an estimated $6.65M and bringing the position to 325,440 shares worth $27.3M. The position accounts for 0.01% of the portfolio, ranked #1824.

Dimensional Fund Advisors first reported a position in DNTH in Q1 2020 and has held it in 18 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Dimensional Fund Advisors held 325,440 shares of Dianthus Therapeutics worth $27.3M as of Q1 2026.
  • Dimensional Fund Advisors bought 114,767 Dianthus Therapeutics shares in Q1 2026, an estimated $6.65M.
  • Dianthus Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1824 holding.
  • Dimensional Fund Advisors first reported a position in Dianthus Therapeutics in Q1 2020 and has held it in 18 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.